Deep Genomics Revenue and Competitors
Estimated Revenue & Valuation
- Deep Genomics's estimated annual revenue is currently $19.8M per year.
- Deep Genomics's estimated revenue per employee is $155,000
- Deep Genomics's total funding is $236.7M.
Employee Data
- Deep Genomics has 128 Employees.
- Deep Genomics grew their employee count by -4% last year.
Deep Genomics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Founder and CEO | Reveal Email/Phone |
2 | Executive Assistant to Founder, Chief Innovation Officer and CEO | Reveal Email/Phone |
3 | CEO | Reveal Email/Phone |
4 | SVP, Platform | Reveal Email/Phone |
5 | VP, Head Software & Data Engineering | Reveal Email/Phone |
6 | VP People Ops | Reveal Email/Phone |
7 | Head Target Identification | Reveal Email/Phone |
8 | Head Research Operations | Reveal Email/Phone |
9 | VP Business Development | Reveal Email/Phone |
10 | Sr. Director, Portfolio Strategy and Management | Reveal Email/Phone |
Deep Genomics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $258.5M | 898 | -10% | $1.1B | $2.4B |
What Is Deep Genomics?
Deep Genomics is using artificial intelligence to build a new universe of life-saving genetic therapies. The future of medicine will rely on artificial intelligence, because biology is too complex for humans to understand. At Deep Genomics, our geneticists, molecular biologists and chemists develop new ways of detecting and treating disease using our biologically accurate artificial intelligence technology.
keywords:Biotechnology, Artificial Intelligence, Therapeutics, Genetic Testing
$236.7M
Total Funding
128
Number of Employees
$19.8M
Revenue (est)
-4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Deep Genomics News
The global spatial genomics and transcriptomics market also declined ... Our secondary data procurement methodology includes deep online and...
Such organizations include Microsoft Corporation, IBM Corporation, NVIDIA Corporation, Deep Genomics, BenevolentAI, Fabric Genomics Inc.,...
Because Deep Genomics targets genetic mutations in rare diseases, it has to step back even further in time. The company notes that for a...
Deep Genomics announced recently that they have closed a $180 million Series C financing round. These are the details. Deep Genomics – a leading artificial intelligence (AI) therapeutics company – announced recently that they have closed a $180 million Series C financing round. SoftBank Vision ...
Photo: Kwanchai Lerttanapunyaporn/Getty Images Canadian startup Deep Genomics scored $180 million in Series C funding for its artificial intelligence technology designed to help program and prioritize transformational RNA therapeutics for genetic diseases. The round was led by SoftBank Vision ...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $18.6M | 128 | 11% | N/A |
#2 | $32.5M | 128 | -1% | N/A |
#3 | $32.5M | 128 | 16% | N/A |
#4 | $26.2M | 128 | N/A | N/A |
#5 | $30M | 128 | N/A | N/A |